Panel Discussion: The Evolving Clinical, Regulatory & Commercial Paradigm in Dermatology

Time: 4:15 pm
day: Day Two


• Assessing the need for cooperation between regulators, payers and drug developers in the definition of appropriate endpoints in the development of dermatological therapies
• Supporting value-based evidence to external stakeholders: Establishing the value of new therapies and effectively demonstrating improved outcomes
• Discussing the different payer requirements between Europe and US
• Navigating the challenges of a crowded development space